Skip to content
LWAY

Lifeway Foods, Inc.

Lifeway Foods, Inc. Q1 FY2026 earnings call

May 14, 2026 · fiscal period ended 2026-03

EPS · actual vs est

$0.30 / $0.30Inline +0.0%

Revenue · actual vs est

$63.0M / $60.8MBeat +3.6%
Ask about this call

Summary

Generated 2026-05-14

Management highlights

  • Financial Performance Summary • Achieved a record-breaking Q1 2026, marking 26 consecutive quarters of year-over-year growth and crossing the $60 million net sales threshold for the first time • Reported net sales of $63 million, up 36.7% year-over-year; gross profit margin expanded 360 basis points to 27.5%, driven by higher core product volume, improved manufacturing efficiency from Waukesha facility upgrades, and favorable conventional milk pricing • SG&A expenses totaled $10.9 million, a 16.8% year-over-year increase, but SG&A as a percentage of revenue fell 300 basis points as marketing and brand-building investments generated strong operating leverage • Net income came in at $4.7 million (31 cents per basic share, 30 cents per diluted share), a 32% increase from $3.5 million in the prior year, demonstrating strong top-to-bottom line earnings flow-through

  • Consumer and Category Tailwinds • The company is positioned to capitalize on growing consumer focus on health, gut health awareness, and demand from the rising population of GLP-1 users seeking nutrient-dense, probiotic-rich satiating foods • Received regulatory/industry validation when full-fat dairy was included in the updated USDA food pyramid, and kefir and fermented foods were highlighted for their digestive health benefits in supporting documents

  • Innovation and New Category Expansion • Launched two new innovative products, Lifeway Muscle Mates and Keeper Butter, following positive feedback at Expo West, and is rolling them out to broader retail and consumer audiences • Entered the pet nutrition category via an innovative partnership with Open Farms to launch the Good Gut premium pet food line, featuring a custom Lifeway-developed probiotic blend for canine gut health, leveraging the company's decades of probiotic and cultured dairy expertise

  • Marketing and Retail Expansion • Deployed experiential and strategic marketing to reach new consumers: partnered with Air One to launch a co-branded Tropical Lifeway Smoothie available at all Air One locations through June 2026, and hosted a 40th anniversary immersive wellness event in Palm Springs that brought together media, influencers and consumers to position Lifeway as a lifestyle brand • Ran a viral social advertising campaign with Chicago football stars Colston Loveland and DeAndre Swift that generated over 10 million views across platforms, and expanded the company's influencer network to grow brand awareness • Secured incremental retail distribution with Costco for a new twin pack of plain Lifeway kefir in select markets, and continues to pursue additional distribution wins across channels aligned with the company's growth strategy

  • Manufacturing Capacity Expansion • Waukesha facility expansion and upgrades are on track for completion by the end of 2026; full capacity is expected to come online in Q1 2027, which will materially increase production capacity, improve operational efficiency, grow the workforce, and strengthen the Midwest as a U.S. hub for kefir manufacturing

View in transcript ↓

Segment performance

The transcript does not break out formal segment-level financial performance with separate absolute amounts and revenue contribution percentages for distinct product segments. All growth is driven by the company's core branded offerings: flagship Lifeway Kefir, which is the bellwether of the business, and high-protein Lifeway Farmer Cheese, which is growing as its reach expands. Net sales for the entire company in Q1 2026 reached $63 million, a 36.7% year-over-year increase, with all expansion volume-led by these two core products.

View in transcript ↓

Guidance

Management did not provide formal full-year or quarterly quantitative guidance, nor any upward/downward guidance revisions in this call. Management confirmed that the Waukesha facility expansion remains on track for completion by the end of 2026, with full capacity coming online in Q1 2027 as previously planned. The company reaffirmed its expectation that ongoing consumer health trends will continue to build demand for its products, and that current strategic investments in manufacturing, innovation, marketing, and sales will support continued market share gain and long-term growth.

View in transcript ↓

Risks

No specific risks, operational failures, or material downside uncertainties were discussed during the prepared remarks portion of the call included in this transcript. Standard forward-looking statement disclaimer language was provided at the opening of the call, noting that actual results could differ materially from projected outcomes, and that the company assumes no obligation to update forward-looking statements except as required by law.

View in transcript ↓

Q&A highlights

No question and answer section was included in the provided earning call transcript.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.30$0.30+0.0%
Revenue$63.0M$60.8M+3.6%

Transcript

May 14, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.